Mariner Investment Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Mariner Investment Group’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-16,448	Closed	-$5.74M	–	119
2016 Q2	$5.74M	Buy	16,448 +8,400	+104%	+$3.24M	1.94%	16
2016 Q1	$2.9M	Buy	8,048 +500	+7%	+$206K	0.8%	44
2015 Q4	$4.1M	Sell	7,548 -3,500	-32%	-$1.9M	0.91%	35
2015 Q3	$5.14M	Buy	11,048 +3,000	+37%	+$1.61M	1.04%	28
2015 Q2	$4.11M	Buy	8,048 +4,000	+99%	+$1.95M	1.05%	27
2015 Q1	$1.83M	Sell	4,048 -4,000	-50%	-$1.7M	0.49%	68
2014 Q4	$3.3M	Buy	8,048 +4,000	+99%	+$1.57M	0.56%	50
2014 Q3	$1.46M	Sell	4,048 -11,000	-73%	-$3.69M	0.3%	82
2014 Q2	$4.25M	Buy	15,048 +12,400	+468%	+$3.68M	0.82%	31
2014 Q1	$795K	Buy	+2,648	New	+$816K	0.17%	100

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Mariner Investment Group's REGN Position: Q3 2016 in Review

Mariner Investment Group sold out of Regeneron Pharmaceuticals (REGN) in Q3 2016, closing a stake of 16,448 shares — an estimated $5.74M sold.

Mariner Investment Group first reported a position in REGN in Q1 2014 and held it in 10 quarters. The position peaked at $5.74M in Q2 2016. 555 funds tracked by Wall St. Rank hold REGN as of Q3 2016.

Mariner Investment Group reported no remaining Regeneron Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Mariner Investment Group sold 16,448 Regeneron Pharmaceuticals shares in Q3 2016, an estimated $5.74M.
Mariner Investment Group first reported a position in Regeneron Pharmaceuticals in Q1 2014 and held it in 10 quarters.
Mariner Investment Group's Regeneron Pharmaceuticals position peaked at $5.74M in Q2 2016.
555 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2016.

Based on Mariner Investment Group's 13F filing for Q3 2016, filed 3 Nov 2016.